Through SLFN5-regulated networks, the analysis revealed that SLFN5-regulated chemokines are involved in inflammation in adipose tissues and the liver in obesity, type 2 diabetes, and metabolic syndrome X as well as the immune system. This evidence concerns the gene SLFN5 and type 2 diabetes mellitus.